1 Product identity
Ingredient risk
1 ingredient to use with caution

Prima Una De Gato

BrandAllergy Research GroupOther Combinations Capsule 7 ingredients 1 caution DSLD #20349
Net contents: 90 Vegetarian Capsule(s)
Target: Adults and Children 4 years and above
DSLD entry: 2013-04-25
2 Ingredients (7)
IngredientGroupSafety
MagnesiumMagnesiumUse with Caution
ManganeseManganeseConditionally Safe
ChromiumChromiumConditionally Safe
Cat's ClawCat's ClawLimited Evidence
ProteaseProteolytic Enzymes (Proteases)
CellulaseCellulase
Hydroxypropyl MethylcelluloseHypromellose
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⚠️ Use with caution — restricted in some markets
Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].
3 Safety cross-reference
Magnesium — Use with Caution
⚠ Diarrhea (especially oxide)
⚠ Accumulates in renal impairment
Manganese — Conditionally Safe
⚠ Neurotoxicity with chronic excess
Chromium — Conditionally Safe
⚠ Hypoglycemia with diabetes meds
⚠ Rare renal/hepatic toxicity
Cat's Claw — Limited Evidence
⚠ May worsen insulin resistance
⚠ Liver fat accumulation
4 Label claims
• All Other
5 Data source
DSLD ID20349
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2013-04-25
6 More from Allergy Research Group
View Allergy Research Group Safety Scorecard → 76 products
Acetyl-Glutathione 300 mgAdrenal CortexAller-Aid Formula IIAmmonium Chloride BufferedBrain Beef Natural GlandularBrainWave Plus
7 Cite this page
Vancouver
Pkhakadze G. Prima Una De Gato — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Jul 29]. Available from: https://supplement.ge/products/prima-una-de-gato-20349/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG